Literature DB >> 1660358

Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats.

T Godfraind1, S Kazda, M Wibo.   

Abstract

Earlier studies have shown that relaxation in response to several agents is impaired in arteries from spontaneously hypertensive rats (SHR). We had previously reported that SHR aortas present a delayed relaxation when first exposed for 35 minutes to a 100 mM KCl solution and then transferred into physiological solution. The first phase of relaxation appeared similar in SHR and Wistar-Kyoto rat arteries, but the second phase was markedly slowed down in SHR arteries, giving rise to a postcontraction tone. In this study, we found that this postcontraction tone could be demonstrated not only in the aorta but also in the mesenteric artery, was independent of the presence of endothelium, increased with the age of SHR, and disappeared progressively when arterial segments were submitted to successive cycles of KCl depolarization followed by reimmersion in physiological solution. Chronic treatment of SHR with nisoldipine at doses that blocked the development of hypertension and attenuated the concomitant hypertrophy of heart and aorta, or in vitro pretreatment of SHR arteries with nisoldipine, decreased the contractile force developed by arteries in response to KCl depolarization and normalized the subsequent relaxation. [3H] (+)-PN200-110 binding studies on heart and brain homogenates indicated an increase in apparent Kd in nisoldipine-fed rats without significant change in Bmax. Binding data were compatible with the view that occupation of dihydropyridine receptors by nisoldipine after chronic oral administration was responsible for the modifications observed ex vivo in the mechanical activity of arteries. We conclude that the postcontraction tone of SHR arteries was mainly due to an abnormally prolonged activation of calcium channels after transfer of depolarized arteries into the physiological solution and that a labile or slowly releasable factor was probably involved in this phenomenon. We suggest that the antihypertensive action of nisoldipine might be related to the mechanisms involved in the suppression of the postcontraction tone as observed in vitro and that this mode of action could be more important than the vasodilating effect of this drug.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660358     DOI: 10.1161/01.res.68.3.674

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

Review 1.  Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.

Authors:  Théophile Godfraind
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 2.  Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications.

Authors:  Swapnil Sonkusare; Philip T Palade; James D Marsh; Sabine Telemaque; Aleksandra Pesic; Nancy J Rusch
Journal:  Vascul Pharmacol       Date:  2006-01-20       Impact factor: 5.773

3.  Disrupting calcium channel expression to lower blood pressure: new targeting of a well-known channel.

Authors:  Swapnil Sonkusare; Mony Fraer; James D Marsh; Nancy J Rusch
Journal:  Mol Interv       Date:  2006-12

Review 4.  Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

Review 5.  Cardioselectivity of calcium antagonists.

Authors:  T Godfraind
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

Review 6.  Pharmacological aspects of calcium antagonism. Short term and long term benefits.

Authors:  W G Nayler
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  Loss of cerebrovascular Shaker-type K(+) channels: a shared vasodilator defect of genetic and renal hypertensive rats.

Authors:  Ann A Tobin; Biny K Joseph; Hamood N Al-Kindi; Sulayma Albarwani; Jane A Madden; Leah T Nemetz; Nancy J Rusch; Sung W Rhee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-01       Impact factor: 4.733

Review 8.  Discovery and Development of Calcium Channel Blockers.

Authors:  Théophile Godfraind
Journal:  Front Pharmacol       Date:  2017-05-29       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.